We thus assessed E-cadherin expression in our series of low- and high-grade serous ovarian cancers, to verify whether any differences occurred in the two series and, if so, whether these differences had any relationship to TAM density. The gene discussed is CDH1; the disease is ovarian serous adenocarcinoma.